
1. J Biol Chem. 2021 Oct 19:101290. doi: 10.1016/j.jbc.2021.101290. [Epub ahead of
print]

Development of a highly specific and sensitive VHH-based sandwich immunoassay for
the detection of the SARS-CoV-2 nucleoprotein.

Gransagne M(1), Aymé G(2), Brier S(3), Chauveau-Le Friec G(2), Meriaux V(2),
Nowakowski M(4), Dejardin F(4), Levallois S(5), Dias de Melo G(6), Donati F(7),
Prot M(8), Brûlé S(9), Raynal B(9), Bellalou J(4), Goncalves P(10), Montagutelli 
X(11), Di Santo JP(10), Lazarini F(12), England P(9), Petres S(4), Escriou N(1), 
Lafaye P(13).

Author information: 
(1)Département de Santé Globale, Institut Pasteur, Paris, France.
(2)Plateforme d'Ingénierie des Anticorps, C2RT, Institut Pasteur, CNRS UMR 3528, 
Paris, France.
(3)Plateforme technologique de RMN biologique, C2RT, Institut Pasteur, CNRS UMR
3528, Paris, France.
(4)Plateforme Technologique Production et Purification de Protéines
Recombinantes, C2RT, Institut Pasteur, CNRS UMR 3528, Paris, France.
(5)Biology of Infection Unit, Institut Pasteur, Inserm U1117, Paris, France.
(6)Lyssavirus Epidemiology and Neuropathology Unit, Institut Pasteur, Paris,
France.
(7)Molecular Genetics of RNA viruses, UMR 3569 CNRS, University of Paris,
Institut Pasteur, Paris, France; National Reference Center for Respiratory
Viruses, Institut Pasteur, Paris, France.
(8)Evolutionary Genomics of RNA viruses, Institut Pasteur, Paris, France.
(9)Plateforme de Biophysique Moléculaire, C2RT, Institut Pasteur, CNRS UMR 3528, 
Paris, France.
(10)Unité d'Immunité Innée, Institut Pasteur, Paris, France; INSERM U1223, Paris,
France.
(11)Mouse Genetics Laboratory, Institut Pasteur, Paris, France.
(12)Perception and Memory Unit, Institut Pasteur, CNRS UMR 3571, Paris, France.
(13)Plateforme d'Ingénierie des Anticorps, C2RT, Institut Pasteur, CNRS UMR 3528,
Paris, France. Electronic address: plafaye@pasteur.fr.

The current COVID-19 pandemic illustrates the importance of obtaining reliable
methods for the rapid detection of SARS-CoV-2. A highly specific and sensitive
diagnostic test able to differentiate the SARS-CoV-2 virus from common human
coronaviruses is therefore needed. Coronavirus nucleoprotein (N) localizes to the
cytoplasm and the nucleolus, and are required for viral RNA synthesis. N is the
most abundant coronavirus protein, so it is of utmost importance to develop
specific antibodies for its detection. In this study, we developed a sandwich
immunoassay to recognize the SARS-CoV-2 N protein. We immunized one alpaca with
recombinant SARS-CoV-2 N and constructed a large single variable domain on heavy 
chain (VHH) antibody library. After phage display selection, 7 VHHs recognizing
the full N protein were identified by ELISA. These VHHs did not recognize the
nucleoproteins of the four common human coronaviruses. Hydrogen Deuterium
eXchange-Mass Spectrometry (HDX-MS) analysis also showed that these VHHs mainly
targeted conformational epitopes in either the C-terminal or the N-terminal
domains. All VHHs were able to recognize SARS-CoV-2 in infected cells or on
infected hamster tissues. Moreover, the VHHs could detect the SARS variants
B.1.17/alpha, B.1.351/beta and P1/gamma. We propose that this sandwich
immunoassay could be applied to specifically detect the SARS-CoV-2 N in human
nasal swabs.

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

DOI: 10.1016/j.jbc.2021.101290 
PMCID: PMC8526496
PMID: 34678315 

Conflict of interest statement: Competing Interests Statement The authors declare
that they have no conflicts of interest with the contents of this article.

